These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2203786)

  • 21. Anti-biotin antibodies offer superior organelle-specific labeling of mitochondria over avidin or streptavidin.
    Hollinshead M; Sanderson J; Vaux DJ
    J Histochem Cytochem; 1997 Aug; 45(8):1053-7. PubMed ID: 9267466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic force measurements of avidin-biotin and streptavdin-biotin interactions using AFM.
    de Odrowaz Piramowicz M; Czuba P; Targosz M; Burda K; Szymoński M
    Acta Biochim Pol; 2006; 53(1):93-100. PubMed ID: 16410837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Versatility of anti-horseradish peroxidase antibody-gold complexes for cytochemistry and in situ hybridization: preparation and application of soluble complexes with streptavidin-peroxidase conjugates and biotinylated antibodies.
    Roth J; Saremaslani P; Zuber C
    Histochemistry; 1992 Nov; 98(4):229-36. PubMed ID: 1459862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorimetric competitive inhibition method for the quantification of avidin, streptavidin and biotin.
    Gan Z; Marquardt RR
    J Biochem Biophys Methods; 1999 Feb; 39(1-2):1-6. PubMed ID: 10344497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A spectrophotometric assay for nanogram quantities of biotin and avidin.
    Niedbala RS; Gergits F; Schray KJ
    J Biochem Biophys Methods; 1986 Nov; 13(4-5):205-10. PubMed ID: 3805573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The FITC-anti-FITC system is a sensitive alternative to biotin-streptavidin in ELISA.
    Harmer IJ; Samuel D
    J Immunol Methods; 1989 Aug; 122(1):115-21. PubMed ID: 2503563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anomalous fluorescence enhancement of Cy3 and cy3.5 versus anomalous fluorescence loss of Cy5 and Cy7 upon covalent linking to IgG and noncovalent binding to avidin.
    Gruber HJ; Hahn CD; Kada G; Riener CK; Harms GS; Ahrer W; Dax TG; Knaus HG
    Bioconjug Chem; 2000; 11(5):696-704. PubMed ID: 10995214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific interactions between adenosine and streptavidin/avidin.
    Bing T; Chang T; Qi C; Zhang N; Liu X; Shangguan D
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7052-5. PubMed ID: 23084893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescence energy transfer-sensitized photobleaching of a fluorescent label as a tool to study donor-acceptor distance distributions and dynamics in protein assemblies: studies of a complex of biotinylated IgM with streptavidin and aggregates of concanavalin A.
    Mekler VM; Averbakh AZ; Sudarikov AB; Kharitonova OV
    J Photochem Photobiol B; 1997 Oct; 40(3):278-87. PubMed ID: 9372617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rational design of biotinylated probes: fluorescent turn-on detection of (strept)avidin and bioimaging in cancer cells.
    Sun Q; Qian J; Tian H; Duan L; Zhang W
    Chem Commun (Camb); 2014 Aug; 50(62):8518-21. PubMed ID: 24948217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of the extent of protein biotinylation by fluorescence binding assay.
    Rao SV; Anderson KW; Bachas LG
    Bioconjug Chem; 1997; 8(1):94-8. PubMed ID: 9026042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fluorometric method for determining the degree of biotinylation of proteins.
    Der-Balin GP; Gomez B; Masino RS; Parce JW
    J Immunol Methods; 1990 Feb; 126(2):281-5. PubMed ID: 2303733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrimination between streptavidin and avidin with fluorescent affinity-based probes.
    Sun Q; Tian H; Qu H; Sun D; Chen Z; Duan L; Zhang W; Qian J
    Analyst; 2015 Jul; 140(13):4648-53. PubMed ID: 25985268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase.
    Yao Z; Zhang M; Kobayashi H; Sakahara H; Nakada H; Yamashina I; Konishi J
    J Nucl Med; 1995 May; 36(5):837-41. PubMed ID: 7738661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioluminescent assays using glucose-6-phosphate dehydrogenase: application to biotin and streptavidin detection.
    Térouanne B; Bencheick M; Balaguer P; Boussioux AM; Nicolas JC
    Anal Biochem; 1989 Jul; 180(1):43-9. PubMed ID: 2479285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotin.
    Rosebrough SF
    Nucl Med Biol; 1993 Jul; 20(5):663-8. PubMed ID: 8358353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of a critical tryptophan to lysine in avidin or streptavidin may explain why sea urchin fibropellin adopts an avidin-like domain.
    Laitinen OH; Airenne KJ; Marttila AT; Kulik T; Porkka E; Bayer EA; Wilchek M; Kulomaa MS
    FEBS Lett; 1999 Nov; 461(1-2):52-8. PubMed ID: 10561495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immobilized nitro-avidin and nitro-streptavidin as reusable affinity matrices for application in avidin-biotin technology.
    Morag E; Bayer EA; Wilchek M
    Anal Biochem; 1996 Dec; 243(2):257-63. PubMed ID: 8954558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A monoclonal antibody to avidin dissociates quaternary structure and curtails biotin binding to avidin and streptavidin.
    Subramanian N; Subramanian S; Karande AA; Adiga PR
    Arch Biochem Biophys; 1997 Aug; 344(2):281-8. PubMed ID: 9264540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of anti-biotin and biotinylated anti-avidin double-bridge and biotinylated tyramide immunohistochemical amplification.
    Freedman LJ; Maddox MT
    J Neurosci Methods; 2001 Nov; 112(1):43-9. PubMed ID: 11640956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.